Please select a day:
02.10.2013
03.10.2013
04.10.2013
05.10.2013
Search

Personal programme
Please enter your email address here in order to bring up your personal programme






Search result



Search Result: Abstracts

Thursday, October 03, 2013

15:45 - 17:00 Poster Session : Immunomodulation/Immunosuppression
Peginterferon beta-1a provides improvements in clinical and radiological disease activity in relapsing-remitting multiple sclerosis: year 1 findings from the phase 3 ADVANCE study P 514
P. Calabresi, B. Kieseier, D. Arnold, L. Balcer, A. Boyko, J. Pelletier, S. Liu, Y. Zhu, X. You, A. Seddighzadeh, B. Sperling, S. Hung, A. Deykin (Baltimore, US; Düsseldorf, DE; Montreal, CA; New York, US; Moscow, RU; Marseille, FR; Cambridge, US)
15:45 - 17:00 Poster Session : Immunomodulation/Immunosuppression
Effect of peginterferon beta-1a on disability progression in patients with relapsing remitting multiple sclerosis: year 1 data from the pivotal phase 3 ADVANCE study P 540
B. Kieseier, P. Calabresi, S. Liu, Y. Zhu, X. You, B. Sperling, S. Sheikh, S. Hung, A. Deykin (Düsseldorf, DE; Baltimore, Cambridge, US)
15:45 - 17:00 Poster Session : Immunomodulation/Immunosuppression
Subgroup and sensitivity analyses of the primary endpoint from the peginterferon beta-1a ADVANCE study: a pivotal phase 3 study in patients with relapsing-remitting multiple sclerosis P 539
B. Kieseier, P. Calabresi, D. Arnold, Y. Zhu, S. Liu, S. Hung, A. Deykin, S. Sheikh (Düsseldorf, DE; Baltimore, US; Montreal, CA; Cambridge, US)
15:45 - 17:00 Poster Session : Risk management for disease modifying treatments
Immunogenicity with peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis: data from the pivotal phase 3 ADVANCE study P 600
J. White, P. Calabresi, Y. Zhu, T. Song, A. Seddighzadeh, S. Hung , A. Deykin, M. Subramanyam (Cambridge, Baltimore, US)

Friday, October 04, 2013

15:30 - 17:00 Poster Session : Risk management for disease modifying treatments
Safety and tolerability of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis: data from the pivotal phase 3 ADVANCE study P 1061
B. Kieseier, P. Calabresi, T. Song, Y. Zhu, S. Hung, A. Deykin, A. Seddighzadeh (Düsseldorf, DE; Baltimore, Cambridge, US)
15:30 - 17:00 Poster Session : Immunomodulation/Immunosuppression
Magnetic resonance imaging results from the first year of the ADVANCE study, a pivotal phase 3 trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis P 989
D. Arnold, P. Calabresi, B. Kieseier, Y. Zhu, S. Liu, S. Hung, A. Deykin, S. Sheikh (Montreal, CA; Baltimore, US; Düsseldorf, DE; Cambridge, US)





show more results